Therapeutic Anti-Tumor Efficacy of DC-Based Vaccines Targeting TME-Associated Antigens Is Improved When Combined with a Chemokine-Modulating Regimen and/or Anti-PD-L1
Article in Vaccines (July 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Vaccines (July 2024)
Preprint in Research Square (February 2024)